查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417534

神經診斷市場報告：2030 年趨勢、預測與競爭分析

Neurodiagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

神經診斷的趨勢和預測

到 2030 年，全球神經診斷市場預計將達到 127 億美元，2024 年至 2030 年複合年成長率為 7.1%。這個市場的主要促進因素是神經系統疾病和神經病變的盛行率不斷增加、患者對準確及時的疾病診斷的興趣不斷提高，以及神經退化性疾病診斷的基因組學和蛋白​​質組學的進步。全球神經診斷市場的未來看起來充滿希望，醫院和外科中心、神經科中心、門診醫療中心、診斷實驗室和影像中心、實驗室和學術實驗室市場都有機會。

神經診斷市場洞察

Lucintel 預測，由於腦部外傷、失智症、巴金森氏症和亨廷頓舞蹈症的盛行率不斷上升，神經退化性疾病在預測期內仍將是最大的部分。

由於其發達的醫療保健系統、醫療相關人員對現代神經診斷設備的廣泛接受以及易於獲得先進的神經診斷技術，北美在預測期內將繼續成為最大的地區。

常問問題

Q1.市場規模有多大？

A1. 到 2030 年，全球神經診斷市場預計將達到 127 億美元。

Q2.市場成長預測如何？

A2. 2024年至2030年，全球神經診斷市場預計將以7.1%的複合年成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3. 該市場的主要驅動力是神經系統疾病和神經病變的盛行率不斷增加、患者對準確及時的疾病診斷的興趣日益濃厚，以及神經退化性疾病診斷的基因組學和蛋白​​質組學的進步。

Q4.市場的主要細分市場是什麼？

A4. 全球神經診斷市場的未來充滿希望，醫院/外科中心、神經內科中心、門診醫療中心、診斷實驗室/影像中心、實驗室/學術實驗室市場都有機會。

Q5. 市場上主要企業有哪些？

A5. 神經診斷領域的主要企業如下。

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon
  • Hitachi
  • Lifelines Neuro Company
  • Natus Medical
  • Hoffman-La Roche
  • FUJIFILM Holdings
  • Mitsar

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，由於腦外傷、失智症、巴金森氏症和亨廷頓舞蹈症的盛行率不斷上升，神經退化性疾病在預測期內仍將是其最大的部分。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 由於其發達的醫療保健系統、醫療相關人員對現代神經診斷設備的廣泛接受以及易於獲得先進的神經診斷技術，北美在預測期內將繼續成為最大的地區。繼續。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球神經診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球神經診斷市場趨勢（2018-2023）與預測（2024-2030）
  • 全球神經診斷市場（按產品）
    • 介紹
    • 診斷和影像系統
    • 臨床檢測設備
    • 試劑及耗材
  • 按狀況分類的全球神經診斷市場
    • 神經退化性疾病
    • 癲癇
    • 中風
    • 頭痛症
    • 睡眠失調
    • 其他
  • 按最終用途分類的全球神經診斷市場
    • 醫院及手術中心
    • 神經中樞
    • 門診治療中心
    • 診斷實驗室和影像中心
    • 研究和學術機構
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球神經診斷市場區域分佈
  • 北美神經診斷市場
  • 歐洲神經診斷市場
  • 亞太神經診斷市場
  • 其他地區神經診斷市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品分類的全球神經診斷市場成長機會
    • 按條件分類的全球神經診斷市場成長機會
    • 按最終用途分類的全球神經診斷市場成長機會
    • 按地區分類的全球神經診斷市場成長機會
  • 全球神經診斷市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球神經診斷市場的產能
    • 全球神經診斷市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon
  • Hitachi
  • Lifelines Neuro Company
  • Natus Medical
  • Hoffman-La Roche
  • FUJIFILM Holdings
  • Mitsar
簡介目錄

Neurodiagnostics Trends and Forecast

The future of the global neurodiagnostics market looks promising with opportunities in the hospital and surgery center, neurology center, ambulatory care center, diagnostic laboratories & imaging center, and research laboratories & academic institute markets. The global neurodiagnostics market is expected to reach an estimated $12.7 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increased prevalence of neurological diseases and disorders, growing patient emphasis on accurate and timely disease diagnosis, as well as, the advancemenet in genomics and proteomics for neurodegenerative disorder diagnosis.

A more than 150-page report is developed to help in your business decisions.

Neurodiagnostics by Segment

The study includes a forecast for the global neurodiagnostics by product, condition, end use, and region.

Neurodiagnostics Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Introduction
  • Diagnostic And Imaging Systems
  • Clinical Testing Instruments
  • Reagents & Consumables

Neurodiagnostics Market by Condition [Shipment Analysis by Value from 2018 to 2030]:

  • Neuro Degenerative Diseases
  • Epilepsy
  • Stroke
  • Headache Disorders
  • Sleep Disorders
  • Others

Neurodiagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals And Surgery Centers
  • Neurology Centers
  • Ambulatory Care Centers
  • Diagnostic Laboratories & Imaging Centers
  • Research Laboratories & Academic Institutes
  • Others

Neurodiagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Neurodiagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neurodiagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurodiagnostics companies profiled in this report include-

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon
  • Hitachi
  • Lifelines Neuro Company
  • Natus Medical
  • Hoffman-La Roche
  • FUJIFILM Holdings
  • Mitsar

Neurodiagnostics Market Insights

Lucintel forecasts that neuro degenerative disease will remain the largest segment over the forecast period due to the prevalence of traumatic brain injuries, dementia, parkinson's disease, and huntington's disease is rising.

North America will remain the largest region over the forecast period due to the presence of a well-developed healthcare system, widespread acceptance of modern neurodiagnostic instruments among medical professionals, and complete accessibility to sophisticated neurodiagnostic technologies.

Features of the Global Neurodiagnostics Market

Market Size Estimates: Neurodiagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neurodiagnostics market size by product, condition, end use, and region in terms of value ($B).

Regional Analysis: Neurodiagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, condition, end use, and regions for the neurodiagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurodiagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the neurodiagnostics market size?

Answer: The global neurodiagnostics market is expected to reach an estimated $12.7 billion by 2030.

Q2. What is the growth forecast for neurodiagnostics market?

Answer: The global neurodiagnostics market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the neurodiagnostics market?

Answer: The major drivers for this market are increased prevalence of neurological diseases and disorders, growing patient emphasis on accurate and timely disease diagnosis, as well as, the advancemenet in genomics and proteomics for neurodegenerative disorder diagnosis.

Q4. What are the major segments for neurodiagnostics market?

Answer: The future of the global neurodiagnostics market looks promising with opportunities in the hospital and surgery center, neurology center, ambulatory care center, diagnostic laboratories & imaging center, and research laboratories & academic institute markets.

Q5. Who are the key neurodiagnostics market companies?

Answer: Some of the key neurodiagnostics companies are as follows.

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon
  • Hitachi
  • Lifelines Neuro Company
  • Natus Medical
  • Hoffman-La Roche
  • FUJIFILM Holdings
  • Mitsar

Q6. Which neurodiagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that neuro degenerative disease will remain the largest segment over the forecast period due to the prevalence of traumatic brain injuries, dementia, parkinson's disease, and huntington's disease is rising.

Q7. In neurodiagnostics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the presence of a well-developed healthcare system, widespread acceptance of modern neurodiagnostic instruments among medical professionals, and complete accessibility to sophisticated neurodiagnostic technologies.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the neurodiagnostics market by product (introduction, diagnostic and imaging systems, clinical testing instruments, and reagents & consumables), condition (neuro degenerative diseases, epilepsy, stroke, headache disorders, sleep disorders, and others), end use (hospitals and surgery centers, neurology centers, ambulatory care centers, diagnostic laboratories & imaging centers, research laboratories & academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neurodiagnostics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Neurodiagnostics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Neurodiagnostics Market by Product
    • 3.3.1: Introduction
    • 3.3.2: Diagnostic and Imaging Systems
    • 3.3.3: Clinical Testing Instruments
    • 3.3.4: Reagents & Consumables
  • 3.4: Global Neurodiagnostics Market by Condition
    • 3.4.1: Neuro Degenerative Diseases
    • 3.4.2: Epilepsy
    • 3.4.3: Stroke
    • 3.4.4: Headache Disorders
    • 3.4.5: Sleep Disorders
    • 3.4.6: Others
  • 3.5: Global Neurodiagnostics Market by End Use
    • 3.5.1: Hospitals and Surgery Centers
    • 3.5.2: Neurology Centers
    • 3.5.3: Ambulatory Care Centers
    • 3.5.4: Diagnostic Laboratories & Imaging Centers
    • 3.5.5: Research Laboratories & Academic Institutes
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Neurodiagnostics Market by Region
  • 4.2: North American Neurodiagnostics Market
    • 4.2.1: North American Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
    • 4.2.2: North American Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
  • 4.3: European Neurodiagnostics Market
    • 4.3.1: European Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
    • 4.3.2: European Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
  • 4.4: APAC Neurodiagnostics Market
    • 4.4.1: APAC Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
    • 4.4.2: APAC Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others
  • 4.5: ROW Neurodiagnostics Market
    • 4.5.1: ROW Neurodiagnostics Market by Condition: Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, and Others
    • 4.5.2: ROW Neurodiagnostics Market by End Use: Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers, Research Laboratories & Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Neurodiagnostics Market by Product
    • 6.1.2: Growth Opportunities for the Global Neurodiagnostics Market by Condition
    • 6.1.3: Growth Opportunities for the Global Neurodiagnostics Market by End Use
    • 6.1.4: Growth Opportunities for the Global Neurodiagnostics Market by Region
  • 6.2: Emerging Trends in the Global Neurodiagnostics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Neurodiagnostics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurodiagnostics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare
  • 7.2: Siemens Healthineers
  • 7.3: Philips Healthcare
  • 7.4: Canon
  • 7.5: Hitachi
  • 7.6: Lifelines Neuro Company
  • 7.7: Natus Medical
  • 7.8: Hoffman-La Roche
  • 7.9: FUJIFILM Holdings
  • 7.10: Mitsar